Publications

• Yap DY, Yung S, Zhang Q, Tang C, Chan TM.Mesangial cell-binding activity of serum immunoglobulin g in patients with lupus nephritis.PLoS One. 2014 Jul 9;9(7):e101987.
• Yap DY, Ma MK, Mok MM, Kwan LP, Chan GC, Chan TM. Long-term data on tacrolimus treatment in lupus nephritis. Rheumatology (Oxford). 2014 Jul 4.
• Yap DY, Yung S, Tang CS, Seto WK, Ma MK, Mok MM, Kwan LP, Chan GC, Choy BY, Yuen MF, Chan TM. Entecavir treatment in kidney transplant recipients infected with hepatitis B. Clin Transplant. 2014 Jun 26.
• Yap DY, Chan TM. Treatment of lupus nephritis: practical issues in Asian countries. Int J Rheum Dis. 2014 Jun 26.
• Chan KY, Benjamin Cheng HW, Yap DY, Yip T, Li CW, Sham MK, Wong YC, Vikki Lau WK. Reduction of Acute Hospital Admissions and Improvement in Outpatient Attendance by Intensified Renal Palliative Care Clinic Follow-Up: The Hong Kong Experience. J Pain Symptom Manage. 2014 May 23.
• Ma MK, Zuo ML, Yap DY, Mok MM, Kwan LP, Chan GC, Siu DC, Chan TM. Chronotropic incompetence, echocardiographic abnormalities and exercise intolerance in renal transplant recipients. J Nephrol. 2014 Apr 23.
• Yap DY, Yung S, Ma MK, Mok MM, Kwan LP, Chan GC, Chan TM. Serum immunoglobulin G level in patients with lupus nephritis and the effect of treatment with corticosteroids and mycophenolatemofetil. Lupus. 2014 Feb 19.
• Yap DY, Chan TM. Evolution of hepatitis B management in kidney transplantation. World J Gastroenterol. 2014 Jan 14; 20:468-74.
• Mok CC, Yap DY*, Navarra SV, Liu ZH, Zhao MH, Lu L, Takeuchi T, Avihingsanon Y, Yu XQ, Lapid EA, Lugue-Lizardo LR, Sumethkul V, Shen N, Chen SL, Chan TM; Asian Lupus Nephritis Network (ALNN). Overview of lupus nephritis management guidelines and perspective from Asia. Nephrology (Carlton). 2014; 19: 11-20. [*co-first author]
• Mok CC, Yap DY*, Navarra SV, Liu ZH, Zhao MH, Lu L, Takeuchi T, Avihingsanon Y, Yu XQ, Lapid EA, Lugue-Lizardo LR, Sumethkul V, Shen N, Chen SL, Chan TM; Asian Lupus Nephritis Network (ALNN). Overview of lupus nephritis management guidelines and perspective from Asia. Int J Rheum Dis. 2013; 16: 25-36. [*co-first author]
• Ma MK, Kwan LP, Mok MM, Yap DY, Tang CS, Chan TM. Significant reduction of Tacrolimus trough level after conversion from twice dailyPrograf to once daily Advagraf in Chinese renal transplant recipients with or without concomitant diltiazem treatment. Ren Fail. 2013; 35: 942-5.
• Choy BY, Lam MF, Yip T, Tang HL, Wong PN, Chow CC, Yap DY, Chan TM. Dosing regimen and tolerability of methoxy polyethylene glycol-epoetin beta in Chinese dialysis patients. Nephrology (Carlton). 2013; 18: 533-8.
• Ma MK, Yap DY, Yip TP, Lui SL, Lo WK. Charlson co-morbidity index and albumin significantly associated with fracture risk in peritoneal dialysis patients. Nephrology (Carlton). 2013; 18: 365-8.
• Yap DY, Lai KN. The role of cytokines in the pathogenesis of systemic lupus erythematosus - from bench to bedside. Nephrology (Carlton). 2013; 18: 243-55.
• Yap DY, Ma MK, Mok MM, Tang CS, Chan TM. Long-term data on corticosteroids and mycophenolatemofetil treatment in Lupus Nephritis. Rheumatology (Oxford) 2013; 52: 480-6.
• Chan TC, Yap DY, Shea YF, Luk JK, Chan FH, Chu LW. Prevalence of anemia in Chinese nursing home older adults: implication of age and renal impairment. GeriatrGerontolInt 2013; 13: 591-6.
• Chan TC, Yap DY, Hung FN, Shea YF, Chu LW, Luk KH, Woo CY, Chan HW. The efficacy of influenza vaccination is reduced in nursing home older adults with moderate to severe renal impairment. J Am Med Dir Assoc. 2013;14:133-6.
• Chan TC, Yap DY, Shea YF, Luk JK, Chu LW, Chan FH. Chronic kidney disease and its association with mortality and hospitalization in Chinese nursing home older residents: a 3-year prospective cohort study. J Am Med Dir Assoc. 2012; 13: 782-7.
• Yap DY, Ma MK, Tang CS, Chan TM. Proliferation Signal Inhibitors (PSI) in the Treatment of Lupus Nephritis - Preliminary Experience. Nephrology (Carlton). 2012; 17: 676-80.
• Chan TC, Yap DY, Shea YF, Luk KH, Chan HW, Chu LW. Prevalence and associated co-morbidities of moderate to severe chronic renal impairment in Chinese nursing home older adults. J Am DirAssoc 2012; 13: 630-3.
• Yap DY, Tang CS, Ma MK, Lam MF, Chan TM. Survival Analysis and Cause of Mortality in patients with Lupus Nephritis. Nephrol Dial Transplant 2012; 27: 3248-54.
• Yap DY, Yu X, Chen XM, Lu F, Chen N, Li XW, So Tang C, Chan TM. Pilot 24 month study to compare mycophenolatemofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome. Nephrology (Carlton) 2012; 17: 352-7.
• Yap DY, Tang CS, Yung S, Choy BY, Yuen MF, Chan TM. Long-Term Outcome of Renal Transplant Recipients with Chronic Hepatitis B Infection-Impact of Antiviral Treatments. Transplantation. 2010; 90: 325-30.
• Yap DY, Chu WL, Ng F, Yip PS, Lui SL, Lo WK. Risk factors and outcome of contamination in patients on peritoneal dialysis - a single centre experience in 15 years. Periton Dial Int 2012; 32: 612-6.
• Yap DY, To KK, Yip PS, Lui SL, Chan TM, Lai KN, Lo WK. Streptococcus bovis peritonitis complicating peritoneal dialysis- a review of 10 years’ experience. Perit Dial Int 2012; 32: 55-9.
• Tang SC, Lin M, Tam S, Au WS, Ma MK, Yap DY, Ho YW, Lai KN. Aliskiren combined with losartan in immunoglobulin A nephropathy: an open-labeled pilot study. Nephrol Dial Transplant. 2011; 27: 613-8.
• Chong YB, Yap DY, Tang CS, Chan TM. Dyslipidaemia in patients with lupus nephritis. Nephrology (Carlton). 2011; 16: 511-7.
• Yap DY, Chu FS, Chu SM, Tam PC, Tam S, Chan TM, Lai KN, Tang SC. CT angiography versus conventional digital angiography in preoperative assessmentfor Chinese living kidney donors. J Nephrol. 2010; 23: 711-6.
• Yap DY, Lai KN. Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances. J Biomed Biotechnol.[Epub 2010 May 6]
• Tse KC, Yap DY, Tang CS, Yung S, Chan TM. Response to adefovir or entecavir in renal allograft recipients with hepatitic flare due to lamivudine-resistant hepatitis B. Clin Transplant. 2010; 24:207-12.
• Tse KC, Tang CS, Lam MF, Yap DY, Chan TM. Cost comparison between mycophenolatemofetil and cyclophosphamide-azathioprine in the treatment of lupus nephritis. J Rheumatol. 2009; 36:76-81.